Quick advancement in glucose control is linked to a temporary worsening of diabetic retinopathy. Mounjaro has not been studied in sufferers with non-proliferative diabetic retinopathy necessitating acute therapy, proliferative diabetic retinopathy, or diabetic macular edema. Limitations of Use: Mounjaro hasn't been analyzed in clients which has a record of pancreatitis. https://docs.google.com/presentation/d/1rm7SvzC4xKC7yajbJdfNyYionunQ34sOKyb0y1K-xhs/edit?usp=sharing